Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: Effect of anticoagulation and its timing: The RAF study

Stroke

Volumn 46, Issue 8, 2015, Pages 2175-2182

  Paciaroni, Maurizio ^a   Agnelli, Giancarlo ^a   Falocci, Nicola ^a   Caso, Valeria ^a   Becattini, Cecilia ^a   Marcheselli, Simona ^b   Rueckert, Christina ^c   Pezzini, Alessandro ^d   Poli, Loris ^d   Padovani, Alessandro ^d   Csiba, Laszló ^e   Szabó, Lilla ^e   Sohn, Sung Il ^f   Tassinari, Tiziana ^g   Abdul Rahim, Azmil H ^h   Michel, Patrik ⁱ   Cordier, Maria ⁱ   Vanacker, Peter ^j   Remillard, Suzette ⁱ   Alberti, Andrea ^a   Venti, Michele ^a   Scoditti, Umberto ^k   Denti, Licia ^k   Orlandi, Giovanni ^l   Chiti, Alberto ^l   Gialdini, Gino ^l   Bovi, Paolo ^m   Carletti, Monica ^m   Rigatelli, Alberto ^m   Putaala, Jukka ⁿ   Tatlisumak, Turgut ⁿ   Masotti, Luca ^o   Lorenzini, Gianni ^o   Tassi, Rossana ^p   Guideri, Francesca ^p   Martini, Giuseppe ^p   Tsivgoulis, Georgios ^q,r,s   Vadikolias, Kostantinos ^q   Liantinioti, Chrissoula ^s   Corea, Francesco ^t   Del Sette, Massimo ^u   Ageno, Walter ^v   De Lodovici, Maria Luisa ^v   Bono, Giorgio ^v   Baldi, Antonio ^w   D'Anna, Sebastiano ^w   Sacco, Simona ^x   Carolei, Antonio ^x   Tiseo, Cindy ^x   Acciarresi, Monica ^a   D'Amore, Cataldo ^a   Imberti, Davide ^y   Zabzuni, Dorjan ^y   Doronin, Boris ^z   Volodina, Vera ^z   Consoli, Domenico ^aa   Galati, Franco ^aa   Pieroni, Alessio ^ab   Toni, Danilo ^ab   Monaco, Serena ^ac   Baronello, Mario Maimone ^ac   Barlinn, Kristian ^ad   Pallesen, Lars Peder ^ad   Kepplinger, Jessica ^ad   Bodechtel, Ulf ^ad   Gerber, Johannes ^ad   Deleu, Dirk ^ae   Melikyan, Gayane ^ae   Ibrahim, Faisal ^ae   Akhtar, Naveed ^ae   Mosconi, Maria Giulia ^a   Bubba, Valentina ^a   Silvestri, Ilenia ^a   Lees, Kennedy R ^h   more..

^a UNIVERSITY OF PERUGIA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c Abteilung Neurologie/Epileptologie   (Germany)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f Keimyung University School of Medicine   (South Korea)

^g SANTA CORONA HOSPITAL   (Italy)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^j ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^k UNIVERSITY OF PARMA   (Italy)

^l UNIVERSITY HOSPITAL OF PISA   (Italy)

^m UNIVERSITY HOSPITAL OF VERONA   (Italy)

ⁿ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^o Internal Medicine Cecina Hospital   (Italy)

^p UNIVERSITY HOSPITAL OF SIENA   (Italy)

^q DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^r ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^s UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^t MOLINETTE HOSPITAL   (Italy)

^u SAPIENZA UNIVERSITY OF ROME   (Italy)

^v UNIVERSITY OF INSUBRIA   (Italy)

^w Ospedale di Portogruaro   (Italy)

^x UNIVERSITY OF L'AQUILA   (Italy)

^y Ospedale Civile di Piacenza   (Italy)

^z Children Clinical Hospital No 1   (Russian Federation)

^aa Jazzolino Hospital   (Italy)

^ab SAPIENZA UNIVERSITY OF ROME   (Italy)

^ac Ospedale Civile Di Vicenza   (Italy)

^ad UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^ae HAMAD MEDICAL CORPORATION   (Qatar)

more..

Author keywords

Anticoagulant therapy; Atrial fibrillation; Hemorrhagic stroke; Ischemic stroke; Secondary prevention

Indexed keywords

ANTIVITAMIN K; APIXABAN; DABIGATRAN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; ASIA; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE ASSESSMENT; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EMBOLISM; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC EMBOLISM; TIME TO TREATMENT; TREATMENT OUTCOME; AGED; CEREBRAL HEMORRHAGE; CLINICAL TRIAL; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; STROKE; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84944698873     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.008891     Document Type: Article

References (18)

1. Hart RG, Coull BM, Hart D. Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke. 1983;14:688-693.
2. Kelley RE, Berger JR, Alter M, Kovacs AG. Cerebral ischemia and atrial fibrillation: prospective study. Neurology. 1984;34:1285-1291.
3. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007;38:423-430. doi: 10.1161/01. STR.0000254600.92975.1f.
4. Whiteley WN, Adams HP Jr, Bath PM, Berge E, Sandset PM, Dennis M, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol. 2013;12:539-545. doi: 10.1016/S1474-4422(13)70079-6.
5. Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V, et al. Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA [Published online ahead of print October 16, 2014]. Eur J Neurol. http://onlinelibrary.wiley.com/doi/10.1111/ene.12577/Abstract: Accessed October 16, 2014.
6. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol. 1993;14:3-13.
7. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008;39:2249-2256. doi: 10.1161/STROKEAHA.107.510321.
8. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329. doi: 10.1056/NEJMoa0804656.
9. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50:1699-1708.
10. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of human brain: brainstem and cerebellum. Neurology. 1996;47:1125-1135.
11. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al; European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318-1322.
12. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263-272. doi: 10.1378/chest.09-1584.
13. Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692-694. doi: 10.1111/j.1538-7836.2005.01204.x.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
15. Beri A, Punnam SR. Anticoagulation in patients with acute ischemic stroke and atrial fibrillation-a balance of risks and benefits. Cardiovasc Drugs Ther. 2008;22:419-425. doi: 10.1007/s10557-008-6122-y.
16. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31:1062-1068.
17. Toni D, Di Angelantonio E, Di Mascio MT, Vinisko R, Bath PM; PRoFESS Study Group. Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial. Int J Stroke. 2014;9:873-878. doi: 10.1111/ijs.12150.
18. Shibazaki K, Kimura K, Aoki J, Saji N, Sakai K. Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation. J Neurol Sci. 2013;331:90-93. doi: 10.1016/j. jns.2013.05.016.